Literature DB >> 14667412

Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis.

Ting Xi Liu1, Niall G Howlett, Min Deng, David M Langenau, Karl Hsu, Jennifer Rhodes, John P Kanki, Alan D D'Andrea, A Thomas Look.   

Abstract

Mechanisms underlying the multiple developmental defects observed in Fanconi anemia (FA) patients are not well defined. We have identified the zebrafish homolog of human FANCD2, which encodes a nuclear effector protein that is monoubiquitinated in response to DNA damage, targeting it to nuclear foci where it preserves chromosomal integrity. Fancd2-deficient zebrafish embryos develop defects similar to those found in children with FA, including shortened body length, microcephaly, and microophthalmia, which are due to extensive cellular apoptosis. Developmental defects and increased apoptosis in Fancd2-deficient zebrafish were corrected by injection of human FANCD2 or zebrafish bcl2 mRNA, or by knockdown of p53, indicating that in the absence of Fancd2, developing tissues spontaneously undergo p53-dependent apoptosis. Thus, Fancd2 is essential during embryogenesis to prevent inappropriate apoptosis in neural cells and other tissues undergoing high levels of proliferative expansion, implicating this mechanism in the congenital abnormalities observed in human infants with FA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667412     DOI: 10.1016/s1534-5807(03)00339-3

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  50 in total

1.  Solute Carrier Family 26 Member a2 (slc26a2) Regulates Otic Development and Hair Cell Survival in Zebrafish.

Authors:  Fei Liu; Wenjun Xia; Jiongjiong Hu; Yingzhi Wang; Fan Yang; Shaoyang Sun; Jin Zhang; Nan Jiang; Huijun Wang; Weidong Tian; Xu Wang; Duan Ma
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

2.  Bax expression and apoptotic cell death in Fanconi anaemia peripheral blood lymphocytes.

Authors:  G A Baruque; M A Bitencourt; R Pasquini; M T L Castelo-Branco; J C Llerena; V M Rumjanek
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

3.  Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.

Authors:  Reena Rani; Jie Li; Qishen Pang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  Developmental Defects Associated With DNA Copy Number Gain of Chromosome 2q33.1: A Case Report and Review of Literature.

Authors:  Akshaya Gupta; Jacob Yo; Gengming Huang; Lynn Soong; Jianli Dong
Journal:  Lab Med       Date:  2018-03-21

6.  Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome.

Authors:  Kelly A McGowan; Wendy W Pang; Rashmi Bhardwaj; Marcelina G Perez; John V Pluvinage; Bertil E Glader; Reem Malek; Susan M Mendrysa; Irving L Weissman; Christopher Y Park; Gregory S Barsh
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

7.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

8.  Zebrafish as a model system to screen radiation modifiers.

Authors:  Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

9.  Functional characterization of human oncoprotein gankyrin in Zebrafish.

Authors:  So Yeon Kim; Wonhee Hur; Jung Eun Choi; Daniel Kim; Jin Sang Wang; Hye Yeon Yoon; Lian Shu Piao; Seung Kew Yoon
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

10.  Heritable and lineage-specific gene knockdown in zebrafish embryo.

Authors:  Mei Dong; Yan-Fang Fu; Ting-Ting Du; Chang-Bin Jing; Chun-Tang Fu; Yi Chen; Yi Jin; Min Deng; Ting Xi Liu
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.